Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs GOAL.MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and GOAL.MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 128 · Grade C

GOAL.MD

Visit GOAL.MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make GOAL.MD a bad call — it's best for readers who prefer authorizing each compounded refill and want to compare complete prepaid charges with shorter purchases. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
57
Transparency
90
88
Access Breadth
93
97
Clinical Oversight
92
70
Track Record
88
37
CoreAge RxBrief Score 94 · 72GOAL.MD

Price, coverage & the tracker

CoreAge RxGOAL.MD
Brief Score94/100 (A)72/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$179/mo per order

Compounded treatment, without automatic billing. Annual plan: $1,188 upfront ($99/mo equivalent). Brand-care fees exclude medication.

Full price details

$179/month compounded semaglutide without automatic billing; $1,188 upfront for the 12-month plan ($99/month equivalent)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$249/mo per order

Compounded treatment, without automatic billing. Annual plan: $1,908 upfront ($159/mo equivalent). Brand-care fees exclude medication.

Full price details

$249/month compounded tirzepatide without automatic billing; $1,908 upfront for the 12-month plan ($159/month equivalent)

CoverageUS only; restrictions by state, confirmed at intakeAdvertises all 50 states, subject to state rules, clinical evaluation and pharmacy eligibility
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

GOAL.MD: Compounded plans are $179 semaglutide and $249 tirzepatide monthly; annual equivalents require $1,188/$1,908 upfront. The $95 brand-access fee excludes medication.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.